T0	Participants 101 125	Hypertension and obesity
T1	Participants 662 698	patients with essential hypertension
T2	Participants 724 742	healthy volunteers
T3	Participants 808 913	85 newly diagnosed patients with untreated essential hypertension were admitted to the outpatient clinic.
T4	Participants 1030 1125	42 patients were randomized into the valsartan group and 43 patients into the amlodipine group.
T5	Participants 1617 1646	obesity-induced hypertension.